MIMEDX to Participate in Upcoming Investor Conferences
MIMEDX (NASDAQ:MDXG) has announced its participation in two upcoming investor conferences in New York. The company's senior management will present at the Cantor Global Healthcare Conference on September 3, 2025, featuring a fireside chat at 1:35 PM ET. Additionally, they will attend the Lake Street BIG9 Best Ideas Growth Conference on September 11, 2025, where they will participate in one-on-one meetings.
Interested investors can arrange meetings with MIMEDX management through their Cantor or Lake Street representatives.
MIMEDX (NASDAQ:MDXG) ha annunciato la sua partecipazione a due prossimi convegni per investitori a New York. Il top management della società presenterà al Cantor Global Healthcare Conference il 3 settembre 2025, con una fireside chat fissata per le 13:35 ET. Inoltre sarà presente al Lake Street BIG9 Best Ideas Growth Conference l'11 settembre 2025, dove terrà incontri one-to-one.
Gli investitori interessati possono organizzare appuntamenti con il management di MIMEDX tramite i loro rappresentanti Cantor o Lake Street.
MIMEDX (NASDAQ:MDXG) ha anunciado su participación en dos próximas conferencias para inversores en Nueva York. La alta dirección de la compañía presentará en el Cantor Global Healthcare Conference el 3 de septiembre de 2025, con una charla informal programada a la 1:35 PM ET. Además, asistirán al Lake Street BIG9 Best Ideas Growth Conference el 11 de septiembre de 2025, donde mantendrán reuniones individuales.
Los inversores interesados pueden concertar reuniones con la dirección de MIMEDX a través de sus representantes de Cantor o Lake Street.
MIMEDX (NASDAQ:MDXG)가 뉴욕에서 열리는 두 건의 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 Cantor Global Healthcare Conference에서 2025년 9월 3일에 발표를 진행하며, 현지 시간 오후 1시 35분(ET)에 파이어사이드 채팅에 참여합니다. 또한 2025년 9월 11일에 개최되는 Lake Street BIG9 Best Ideas Growth Conference에 참석하여 일대일 미팅을 진행할 예정입니다.
관심 있는 투자자는 Cantor 또는 Lake Street 담당자를 통해 MIMEDX 경영진과의 미팅을 주선할 수 있습니다.
MIMEDX (NASDAQ:MDXG) a annoncé sa participation à deux prochaines conférences investisseurs à New York. La direction générale présentera au Cantor Global Healthcare Conference le 3 septembre 2025, avec une discussion au coin du feu à 13h35 ET. Elle participera également au Lake Street BIG9 Best Ideas Growth Conference le 11 septembre 2025, où des réunions individuelles seront organisées.
Les investisseurs intéressés peuvent organiser des rendez‑vous avec la direction de MIMEDX via leurs représentants Cantor ou Lake Street.
MIMEDX (NASDAQ:MDXG) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen in New York angekündigt. Das Senior Management des Unternehmens wird am Cantor Global Healthcare Conference am 3. September 2025 präsentieren und um 13:35 Uhr ET an einem Fireside-Chat teilnehmen. Außerdem werden sie am Lake Street BIG9 Best Ideas Growth Conference am 11. September 2025 teilnehmen und Einzelgespräche führen.
Interessierte Investoren können Treffen mit dem Management von MIMEDX über ihre Cantor- oder Lake Street-Vertreter vereinbaren.
- None.
- None.
MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Cantor Global Healthcare Conference | New York, NY
Wednesday, September 3, 2025
Fireside Chat (1:35 PM ET): Click here to access
Lake Street BIG9 Best Ideas Growth Conference | New York, NY
Thursday, September 11, 2025
1:1 sessions
Investors interested in meeting with senior management at these events may contact their respective Cantor or Lake Street representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
